Quantbot Technologies LP Exelixis, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

A detailed history of Quantbot Technologies LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 5,748 shares of EXEL stock, worth $201,467. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,748
Holding current value
$201,467
% of portfolio
0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$21.96 - $27.6 $126,226 - $158,644
5,748 New
5,748 $149,000
Q3 2023

Nov 07, 2023
BUY
$19.04 - $22.74 $62,394 - $74,518
3,277 Added 131.45%
5,770 $126,000
Q2 2023

Aug 08, 2023
BUY
$18.17 - $20.48 $45,297 - $51,056
2,493 New
2,493 $47,000
Q2 2022

Aug 09, 2022
BUY
$17.44 - $23.16 $87 - $115
5 New
5 $0
Q4 2021

Feb 11, 2022
SELL
$15.84 - $21.88 $683,717 - $944,428
-43,164 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$16.3 - $21.14 $703,573 - $912,486
43,164 New
43,164 $912,000
Q1 2021

May 14, 2021
SELL
$20.53 - $25.22 $145,763 - $179,062
-7,100 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$18.39 - $24.8 $49,836 - $67,208
2,710 Added 61.73%
7,100 $142,000
Q3 2020

Nov 16, 2020
BUY
$20.67 - $26.94 $57,669 - $75,162
2,790 Added 174.38%
4,390 $107,000
Q2 2020

Aug 13, 2020
BUY
$16.46 - $27.42 $26,336 - $43,872
1,600 New
1,600 $37,000
Q4 2019

Feb 10, 2020
SELL
$15.15 - $18.89 $1,499 - $1,870
-99 Closed
0 $0
Q3 2019

Nov 12, 2019
SELL
$17.68 - $22.65 $106,097 - $135,922
-6,001 Reduced 98.38%
99 $1,000
Q2 2019

Aug 13, 2019
SELL
$18.93 - $24.75 $25,858 - $33,808
-1,366 Reduced 18.3%
6,100 $130,000
Q1 2019

May 13, 2019
SELL
$19.6 - $24.76 $666 - $841
-34 Reduced 0.45%
7,466 $177,000
Q4 2018

Feb 13, 2019
BUY
$13.65 - $21.8 $102,375 - $163,500
7,500 New
7,500 $147,000
Q3 2018

Nov 13, 2018
SELL
$15.87 - $22.4 $134,895 - $190,400
-8,500 Closed
0 $0
Q2 2018

Aug 13, 2018
SELL
$18.56 - $22.45 $293,377 - $354,867
-15,807 Reduced 65.03%
8,500 $182,000
Q1 2018

May 11, 2018
BUY
$22.15 - $31.89 $538,400 - $775,150
24,307 New
24,307 $538,000
Q4 2017

Feb 12, 2018
SELL
$24.23 - $30.93 $479,875 - $612,568
-19,805 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$23.35 - $29.24 $462,446 - $579,098
19,805
19,805 $479,000

Others Institutions Holding EXEL

# of Institutions
498
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email